A breakthrough in medical research conducted by researchers in the US claim to have confirmed the link between inflammation and heart attacks.

The anti-inflammatory drug, Canukinumab, was tested on over 10,000 heart attack survivors over the past 4 years. The results indicated that the drug can combat the likelihood of a second heart attack  by 25%.

However, concerns surround the reliability and cost of the study.

Producers:

Speakers: